Gary Cannon
Family Medicine · Collinsville, OKNPI 1659357051
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 535 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,447 and has fallen 80.6% since, to $474 in 2023. Among family medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 535 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$921
- Novo Nordisk$621
- Pfizer$611
- GSK$606
- Boehringer Ingelheim$483
- Johnson & Johnson$480
- plus $4K from 31 others
What the payments were for
- Food & beverage$8,015100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $921 |
| Novo Nordisk | 53 | $621 |
| Pfizer | 45 | $611 |
| GSK | 52 | $606 |
| Boehringer Ingelheim | 31 | $483 |
| Johnson & Johnson | 33 | $480 |
| Amgen | 29 | $480 |
| Merck | 32 | $407 |
| AbbVie(2 entities) | 20 | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $387 |
| Lilly USA, LLC | 26 | $380 |
| Kowa Pharmaceuticals America, Inc. | 23 | $344 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $279 |
| E.r. Squibb & Sons, L.L.C. | 13 | $169 |
| Novartis | 9 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $136 |
| Antares Pharma, Inc. | 10 | $135 |
| Esperion Therapeutics, Inc. | 8 | $134 |
| Bayer | 6 | $109 |
| Amarin Pharma, Inc. | 6 | $99 |
| Arbor Pharmaceuticals, Inc. | 6 | $95 |
| Biohaven Pharmaceuticals, Inc. | 6 | $88 |
| Kaleo, Inc. | 6 | $87 |
| Eisai Inc. | 5 | $78 |
| Currax Pharmaceuticals LLC | 6 | $77 |
| Genentech USA, Inc. | 4 | $61 |
| Astellas Pharma US Inc | 4 | $57 |
| Aytu Biopharma, Inc. | 2 | $24 |
| Biogen | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Abbott | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Alk-abello, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$105
- BEVESPI AEROSPHERE$105
- BREZTRI$101
How this compares
$8,029 in reported general payments places this provider in the 90th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Collinsville
- Yancy GalutiaCollinsville$14K
- Robert DeanCollinsville$13K
- William StringerCollinsville$13K
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Lisa ConneryNorman$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.